Long-Term Follow-Up of a Glucocorticoid Minimizing Regimen for the Treatment of Severe Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
Stephen P. McAdoo(Imperial College Healthcare NHS Trust), Charles D. Pusey(Imperial College Healthcare NHS Trust), Tony Lopez(Imperial College Healthcare NHS Trust), Sally Hamour(Imperial College London), Megan Griffith(Imperial College Healthcare NHS Trust), Maria Prendecki(Imperial College Healthcare NHS Trust), Tom Cairns(Imperial College Healthcare NHS Trust), Jeremy Levy(Imperial College Healthcare NHS Trust), Amrita Dhutia(Imperial College Healthcare NHS Trust), Mark A. Little(Trinity College Dublin), Ruth J. Pepper(University College Hospital), Marie Condon(Imperial College Healthcare NHS Trust), Áine Burns(The Royal Free Hospital), Alan D. Salama(The Royal Free Hospital)
Cited by 6
Related Papers
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
|Annals of the Rheumatic Diseases|2013|454
CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis
|Journal of Clinical Investigation|2000|176
Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids
|Nephrology Dialysis Transplantation|2009|156